Works by Tavori, Hagai

Results: 22

The biology of PCSK9 inhibition: some unanswered questions.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1345

By:

Lambert, Gilles;
Diotel, Nicolas;
Tavori, Hagai

Publication type:

Article

PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.

Published in:

Journal of Neuroscience, 2019, v. 39, n. 27, p. 5404, doi. 10.1523/jneurosci.2942-18.2019

By:

Ye Zhou;
Miles, Joshua R.;
Tavori, Hagai;
Min Lin;
Khoshbouei, Habibeh;
Borchelt, David R.;
Bazick, Hannah;
Landreth, Gary E.;
Lee, Sooyeon;
Fazio, Sergio;
Notterpek, Lucia

Publication type:

Article

PMP22 Is Critical for Actin-Mediated Cellular Functions and for Establishing Lipid Rafts.

Published in:

Journal of Neuroscience, 2014, v. 34, n. 48, p. 16140, doi. 10.1523/JNEUROSCI.1908-14.2014

By:

Sooyeon Lee;
Amici, Stephanie;
Tavori, Hagai;
Zeng, Waylon M.;
Freeland, Steven;
Fazio, Sergio;
Notterpek, Lucia

Publication type:

Article

Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.

Published in:

2019

By:

Shapiro, Michael D;
Minnier, Jessica;
Tavori, Hagai;
Kassahun, Helina;
Flower, Andrea;
Somaratne, Ransi;
Fazio, Sergio

Publication type:

journal article

Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 10, p. 648, doi. 10.3390/metabo11100648

By:

Lindner, Jonathan R.;
Davidson, Brian P.;
Song, Zifeng;
Maier, Claudia S.;
Minnier, Jessica;
Stevens, Jan Frederick;
Ferencik, Maros;
Taqui, Sahar;
Belcik, J. Todd;
Moccetti, Federico;
Layoun, Michael;
Spellman, Paul;
Turker, Mitchell S.;
Tavori, Hagai;
Fazio, Sergio;
Raber, Jacob;
Bobe, Gerd

Publication type:

Article

New developments in atherosclerosis: clinical potential of PCSK9 inhibition.

Published in:

Vascular Health & Risk Management, 2015, v. 11, p. 493, doi. 10.2147/VHRM.S74692

By:

Giunzioni, Ilaria;
Tavori, Hagai

Publication type:

Article

New developments in atherosclerosis: clinical potential of PCSK9 inhibition.

Published in:

2015

By:

Giunzioni, Ilaria;
Tavori, Hagai

Publication type:

journal article

Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Published in:

Cardiovascular Research, 2016, v. 112, n. 1, p. 429, doi. 10.1093/cvr/cvw194

By:

Norata, Giuseppe Danilo;
Tavori, Hagai;
Pirillo, Angela;
Fazio, Sergio;
Catapano, Alberico L.

Publication type:

Article

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Published in:

Cardiovascular Research, 2016, v. 110, n. 2, p. 268, doi. 10.1093/cvr/cvw053

By:

Tavori, Hagai;
Giunzioni, Ilaria;
Predazzi, Irene M.;
Plubell, Deanna;
Shivinsky, Anna;
Miles, Joshua;
Devay, Rachel M.;
Liang, Hong;
Rashid, Shirya;
Linton, MacRae F.;
Fazio, Sergio

Publication type:

Article

Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.

Published in:

2018

By:

Shapiro, Michael D.;
Miles, Joshua;
Tavori, Hagai;
Fazio, Sergio

Publication type:

journal article

Targeting PCSK9 for Therapeutic Gains.

Published in:

Current Atherosclerosis Reports, 2015, v. 17, n. 4, p. 1, doi. 10.1007/s11883-015-0499-4

By:

Shapiro, Michael;
Fazio, Sergio;
Tavori, Hagai

Publication type:

Article

Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

Published in:

2017

By:

Fazio, Sergio;
Minnier, Jessica;
Shapiro, Michael D;
Tsimikas, Sotirios;
Tarugi, Patrizia;
Averna, Maurizio R;
Arca, Marcello;
Tavori, Hagai

Publication type:

journal article

Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction.

Published in:

Expert Review of Cardiovascular Therapy, 2014, v. 12, n. 10, p. 1137, doi. 10.1586/14779072.2014.954551

By:

Tavori, Hagai;
Melone, Michelle;
Rashid, Shirya

Publication type:

Article

Subcellular diversion of cholesterol by gain‐ and loss‐of‐function mutations in PMP22.

Published in:

Glia (0894-1491), 2020, v. 68, n. 11, p. 2300, doi. 10.1002/glia.23840

By:

Zhou, Ye;
Borchelt, David;
Bauson, Jodi C.;
Fazio, Sergio;
Miles, Joshua R.;
Tavori, Hagai;
Notterpek, Lucia

Publication type:

Article

Dyslipidemia, insulin resistance, and impairment of placental metabolism in the offspring of obese mothers.

Published in:

Journal of Developmental Origins of Health & Disease, 2021, v. 12, n. 5, p. 738, doi. 10.1017/S2040174420001026

By:

Bucher, Matthew;
Montaniel, Kim Ramil C.;
Myatt, Leslie;
Weintraub, Susan;
Tavori, Hagai;
Maloyan, Alina

Publication type:

Article

Role of PAI-1 in hepatic steatosis and dyslipidemia.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-79948-x

By:

Levine, Joshua A.;
Oleaga, Carlota;
Eren, Mesut;
Amaral, Ansel P.;
Shang, Meng;
Lux, Elizabeth;
Khan, Sadiya S.;
Shah, Sanjiv J.;
Omura, Yasuhiro;
Pamir, Nathalie;
Hay, Joshua;
Barish, Grant;
Miyata, Toshio;
Tavori, Hagai;
Fazio, Sergio;
Vaughan, Douglas E.

Publication type:

Article

Development of a novel Guinea Pig model producing transgenerational endothelial transcriptional changes driven by maternal food restriction and a second metabolic insult of high fat diet.

Published in:

Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1266444

By:

Le, Hillary H.;
Hagen, Matthew W.;
Louey, Samantha;
Tavori, Hagai;
Thornburg, Kent L.;
Giraud, George D.;
Hinds, Monica T.;
Barnes, Anthony P.

Publication type:

Article

Development of a novel Guinea Pig model producing transgenerational endothelial transcriptional changes driven by maternal food restriction and a second metabolic insult of high fat diet.

Published in:

Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1266444

By:

Le, Hillary H.;
Hagen, Matthew W.;
Louey, Samantha;
Tavori, Hagai;
Thornburg, Kent L.;
Giraud, George D.;
Hinds, Monica T.;
Barnes, Anthony P.

Publication type:

Article

Angiotensin-Induced Abdominal Aortic Aneurysms in Hypercholesterolemic Mice: Role of Serum Cholesterol and Temporal Effects of Exposure.

Published in:

PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084517

By:

Prins, Petra A.;
Hill, Michael F.;
Airey, David;
Nwosu, Sam;
Perati, Prudhvidhar R.;
Tavori, Hagai;
F. Linton, MacRae;
Kon, Valentina;
Fazio, Sergio;
Sampson, Uchechukwu K.

Publication type:

Article

Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity.

Published in:

2019

By:

Tavori, Hagai;
Fenton, Alexandra M;
Plubell, Deanna L;
Rosario, Sara;
Yerkes, Elisabeth;
Gasik, Rayna;
Miles, Joshua;
Bergstrom, Paige;
Minnier, Jessica;
Fazio, Sergio;
Pamir, Nathalie

Publication type:

journal article

Local effects of human PCSK9 on the atherosclerotic lesion.

Published in:

Journal of Pathology, 2016, v. 238, n. 1, p. 52, doi. 10.1002/path.4630

By:

Giunzioni, Ilaria;
Tavori, Hagai;
Covarrubias, Roman;
Major, Amy S;
Ding, Lei;
Zhang, Youmin;
DeVay, Rachel M;
Hong, Liang;
Fan, Daping;
Predazzi, Irene M;
Rashid, Shirya;
Linton, MacRae F;
Fazio, Sergio

Publication type:

Article

Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 10, p. 4793, doi. 10.1210/jc.2018-02708

By:

Tavori, Hagai;
Fenton, Alexandra M.;
Plubell, Deanna L.;
Rosario, Sara;
Yerkes, Elisabeth;
Gasik, Rayna;
Miles, Joshua;
Bergstrom, Paige;
Minnier, Jessica;
Fazio, Sergio;
Pamir, Nathalie

Publication type:

Article